Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Guangdong Jiaying Pharmaceutical Co Ltd cash flow-to-debt ratio. Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Cash Flow-to-Debt Ratio of -0.70x as of September 2025, meaning its operating cash flow of CN¥-45.73 Million could theoretically repay -1% of its total liabilities (CN¥65.72 Million) in one year. Check Guangdong Jiaying Pharmaceutical Co Ltd (002198) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Cash flow-to-debt ratio of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. Historical debt coverage capacity for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. Check Guangdong Jiaying Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2004–2025)
Guangdong Jiaying Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for Guangdong Jiaying Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guangdong Jiaying Pharmaceutical Co Ltd (002198) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥9.00 Million | CN¥131.30 Million | ▼ -90.9% |
| 2024 | 0.75x | CN¥60.85 Million | CN¥80.60 Million | ▼ -35.1% |
| 2023 | 1.16x | CN¥98.45 Million | CN¥84.58 Million | ▲ +406.8% |
| 2022 | 0.23x | CN¥27.15 Million | CN¥118.23 Million | ▼ -45.5% |
| 2021 | 0.42x | CN¥51.80 Million | CN¥122.85 Million | ▼ -45.4% |
| 2020 | 0.77x | CN¥96.87 Million | CN¥125.43 Million | ▲ +1048.4% |
| 2019 | 0.07x | CN¥12.96 Million | CN¥192.77 Million | ▼ -88.7% |
| 2018 | 0.60x | CN¥62.10 Million | CN¥104.21 Million | ▲ +146.7% |
| 2017 | 0.24x | CN¥30.63 Million | CN¥126.80 Million | ▼ -48.0% |
| 2016 | 0.46x | CN¥53.13 Million | CN¥114.38 Million | ▲ +29.9% |
| 2015 | 0.36x | CN¥42.31 Million | CN¥118.30 Million | ▼ -40.5% |
| 2014 | 0.60x | CN¥103.36 Million | CN¥171.94 Million | ▲ +237.8% |
| 2013 | 0.18x | CN¥19.46 Million | CN¥109.35 Million | ▲ +22.1% |
| 2012 | 0.15x | CN¥5.27 Million | CN¥36.17 Million | ▲ +571.8% |
| 2011 | 0.02x | CN¥781.89K | CN¥36.04 Million | ▼ -95.3% |
| 2010 | 0.46x | CN¥19.70 Million | CN¥42.40 Million | ▼ -80.2% |
| 2009 | 2.35x | CN¥27.98 Million | CN¥11.91 Million | ▲ +95.1% |
| 2008 | 1.20x | CN¥10.71 Million | CN¥8.89 Million | ▲ +115.7% |
| 2007 | 0.56x | CN¥18.35 Million | CN¥32.85 Million | ▼ -20.7% |
| 2006 | 0.70x | CN¥26.37 Million | CN¥37.42 Million | ▲ +7.3% |
| 2005 | 0.66x | CN¥17.63 Million | CN¥26.84 Million | ▲ +71.6% |
| 2004 | 0.38x | CN¥8.78 Million | CN¥22.95 Million | — |